BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21084154)

  • 1. Changes in fetal and maternal Doppler parameters observed during acute severe hypertension treatment with hydralazine or labetalol: a randomized controlled trial.
    Baggio MR; Martins WP; Calderon AC; Berezowski AT; Marcolin AC; Duarte G; Cavalli RC
    Ultrasound Med Biol; 2011 Jan; 37(1):53-8. PubMed ID: 21084154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal and fetal haemodynamics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalol.
    Harper A; Murnaghan GA
    Br J Obstet Gynaecol; 1991 May; 98(5):453-9. PubMed ID: 2059591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To study the changes in fetal hemodynamics with intravenous labetalol or nifedipine in acute severe hypertension.
    Gainder S; Thakur M; Saha SC; Prakash M
    Pregnancy Hypertens; 2019 Jan; 15():12-15. PubMed ID: 30825908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy.
    Mabie WC; Gonzalez AR; Sibai BM; Amon E
    Obstet Gynecol; 1987 Sep; 70(3 Pt 1):328-33. PubMed ID: 3306494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial.
    Vigil-De Gracia P; Lasso M; Ruiz E; Vega-Malek JC; de Mena FT; López JC;
    Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):157-62. PubMed ID: 16621226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Labetalol decreases cerebral perfusion pressure without negatively affecting cerebral blood flow in hypertensive gravidas.
    Belfort MA; Tooke-Miller C; Allen JC; Dizon-Townson D; Varner MA
    Hypertens Pregnancy; 2002; 21(3):185-97. PubMed ID: 12517326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of severe hypertension in the postpartum period with intravenous hydralazine or labetalol: a randomized clinical trial.
    Vigil-De Gracia P; Ruiz E; López JC; de Jaramillo IA; Vega-Maleck JC; Pinzón J
    Hypertens Pregnancy; 2007; 26(2):163-71. PubMed ID: 17469006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of acute pregnancy-related hypertension: labetalol and hydralazine compared.
    Walker JJ; Greer I; Calder AA
    Postgrad Med J; 1983; 59 Suppl 3():168-70. PubMed ID: 6647203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor analysis, including antihypertensive medication, of the outcome of pregnancy in pregnancy-associated hypertension.
    Hussein M; Mooij JM; Roujouleh H
    Kidney Blood Press Res; 2001; 24(2):124-8. PubMed ID: 11435745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive drugs in pregnancy.
    Naden RP; Redman CW
    Clin Perinatol; 1985 Oct; 12(3):521-38. PubMed ID: 2865023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. To study the changes in maternal hemodynamics with intravenous labetalol or nifedipine in acute severe hypertension.
    Thakur M; Gainder S; Saha SC; Prakash M
    Pregnancy Hypertens; 2020 Jul; 21():180-183. PubMed ID: 32570152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis.
    Magee LA; Cham C; Waterman EJ; Ohlsson A; von Dadelszen P
    BMJ; 2003 Oct; 327(7421):955-60. PubMed ID: 14576246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks of parenteral antihypertensive therapy for the treatment of severe maternal hypertension are low.
    Sharma KJ; Rodriguez M; Kilpatrick SJ; Greene N; Aghajanian P
    Hypertens Pregnancy; 2016; 35(1):123-8. PubMed ID: 26910380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials.
    Sridharan K; Sequeira RP
    Br J Clin Pharmacol; 2018 Sep; 84(9):1906-1916. PubMed ID: 29974489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal haemodynamics before and after treatment of maternal hypertension in pregnancy.
    Rasmussen K
    Dan Med Bull; 1987 Jun; 34(3):170-2. PubMed ID: 3595214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of umbilical artery Doppler velocimetry between maternal supine position and complete left lateral position in predicting obstetric complications.
    Ryo E; Okai T; Takagi K; Okuno S; Sadatsuki M; Kaneko M; Taketani Y
    Ultrasound Obstet Gynecol; 1998 Jun; 11(6):415-8. PubMed ID: 9674088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol.
    Elatrous S; Nouira S; Ouanes Besbes L; Marghli S; Boussarssar M; Sakkouhi M; Abroug F
    Intensive Care Med; 2002 Sep; 28(9):1281-6. PubMed ID: 12209278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Committee Opinion No. 692: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period.
    Committee on Obstetric Practice
    Obstet Gynecol; 2017 Apr; 129(4):e90-e95. PubMed ID: 28333820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal diastolic function in asymptomatic pregnant women with bilateral notching of the uterine artery waveform at 24 weeks' gestation: a pilot study.
    Valensise H; Vasapollo B; Novelli GP; Larciprete G; Romanini ME; Arduini D; Galante A; Romanini C
    Ultrasound Obstet Gynecol; 2001 Nov; 18(5):450-5. PubMed ID: 11844163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Committee Opinion No. 692 Summary: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period.
    Obstet Gynecol; 2017 Apr; 129(4):769-770. PubMed ID: 28333812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.